Table 1. Number of analyzed paired and unpaired tumor samples from each cancer type: breast carcinoma (BRCA), colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), kidney chromophobe (KICH), kidney renal clear-cell carcinoma (KIRC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD) and thyroid carcinoma (THCA).
| TCGA acronym | Cancer type | Paired samples | Unpaired tumor samples | Reference |
|---|---|---|---|---|
| BRCA | Breast invasive carcinoma | 107 | 929 | (3) |
| COAD | Colon adenocarcinoma | 26 | 236 | (1) |
| HNSC | Head/neck squamous cell carcinoma | 38 | 384 | (27) |
| KICH | Kidney chromophobe | 21 | 41 | https://tcga-data.nci.nih.gov/ |
| KIRC | Kidney renal clear cell carcinoma | 71 | 434 | (4) |
| LUAD | Lung adenocarcinoma | 57 | 431 | (28) |
| LUSC | Lung squamous cell carcinoma | 50 | 433 | (2) |
| PRAD | Prostate adenocarcinoma | 48 | 247 | https://tcga-data.nci.nih.gov/ |
| THCA | Thyroid carcinoma | 58 | 439 | https://tcga-data.nci.nih.gov/ |
All data sets were obtained from https://tcga-data.nci.nih.gov/. For the paired samples we also used the corresponding normal samples from the same patients. For the list of samples used see Supplementary File S1.